Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87.4M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
14.7M
-
Shares change
-
-5.88M
-
Total reported value, excl. options
-
$4.61M
-
Value change
-
-$2.19M
-
Number of buys
-
12
-
Number of sells
-
-11
-
Price
-
$0.31
Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q4 2024
38 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.7M shares
of 87.4M outstanding shares and own 16.83% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.36M shares), TIFF ADVISORY SERVICES, LLC (2.98M shares), CINCINNATI INSURANCE CO (2.03M shares), VANGUARD GROUP INC (1.75M shares), Balyasny Asset Management L.P. (1.73M shares), FreeGulliver LLC (601K shares), GEODE CAPITAL MANAGEMENT, LLC (347K shares), FourWorld Capital Management LLC (257K shares), BlackRock, Inc. (254K shares), and RENAISSANCE TECHNOLOGIES LLC (182K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.